$JAGX News Article - Jaguar Health Subsidiary Napo
Post# of 132
(Total Views: 324)
Posted On: 10/07/2020 8:50:48 AM
$JAGX News Article - Jaguar Health Subsidiary Napo Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Crofelemer (Mytesi) for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy https://marketwirenews.com/news-releases/jagu...50790.html
(0)
(0)Jaguar Health Inc. (JAGX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼